Lv54
1490 积分 2024-03-26 加入
ICH-Q3D based elemental impurities study in an oral drug product: Risk assessment according to the component approach (option 2b) confirmed by the finished product analysis (option 3)
17天前
已关闭
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
1个月前
已完结
Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
1个月前
已完结
Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis
2个月前
已完结
Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open‐label, Australian study
2个月前
已完结
Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis
2个月前
已完结
Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)
2个月前
已完结
Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration
2个月前
已完结
Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease
2个月前
已完结
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
2个月前
已完结
皖公网安备34019202002308
